Educational Intervention for Prostate Cancer
(IMPRINT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to increase the number of men with prostate cancer who undergo germline testing, which identifies inherited genetic mutations that could influence treatment or family risk. The trial employs an educational intervention, known as simulation-based education or interdisciplinary counseling training, delivered either in person or online, to inform participants about the benefits and process of germline testing. Men with prostate cancer who have not previously undergone this type of genetic testing are ideal candidates for the trial. As an unphased trial, it provides participants with the opportunity to gain valuable insights into their genetic health and potentially enhance their treatment options.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this educational intervention is safe?
Research has shown that educational programs, like the one in this trial, are generally safe for participants. One study examined peer-based education about genetic testing for prostate cancer and found it increased understanding without harmful effects. Another study demonstrated that educational sessions can enhance knowledge and attitudes about health without causing negative effects.
These findings suggest that educational programs, whether in-person or online, are well-received. They improve understanding and attitudes about health topics without known risks to participants. Therefore, joining this educational session should be safe and informative.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on an educational intervention for prostate cancer, specifically aimed at improving understanding of germline testing. Unlike traditional treatments such as surgery, radiation, or hormone therapy, which directly target the cancer itself, this intervention empowers patients through knowledge. By providing in-clinic or virtual sessions with trained educators, the approach aims to enhance patient decision-making and potentially improve outcomes by ensuring patients are better informed about their genetic risks and treatment options. This educational strategy is unique because it addresses the often-overlooked aspect of patient education in cancer care, which can lead to more personalized and effective treatment plans.
What evidence suggests that this educational intervention is effective for improving germline testing rates in prostate cancer?
Research has shown that educational programs effectively increase knowledge and improve attitudes about prostate cancer. In this trial, participants will receive an educational intervention, including in-clinic or virtual sessions on germline testing in prostate cancer with a trained educator. One study found that education based on the health belief model led to better understanding and healthier views about prostate cancer. Another study demonstrated that educational sessions greatly improved knowledge, confidence in taking action, and social support. These findings suggest that attending an educational session can significantly aid in understanding and managing prostate cancer.12356
Who Is on the Research Team?
Rana McKay, MD
Principal Investigator
UCSD
Are You a Good Fit for This Trial?
This trial is for men aged 18 or older who have been diagnosed with prostate cancer and meet the NCCN guidelines for germline testing. It's not open to those who've already had germline testing or have positive somatic genetic tests suggesting a possible inherited variant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Educational Intervention
Participants undergo a one-on-one educational session regarding the rationale and benefits/risks of germline testing
Germline Testing
Participants who consent proceed with germline testing via a commercial assay
Follow-up
Participants are monitored for changes in knowledge and attitudes towards germline testing, and the impact on prostate cancer management
What Are the Treatments Tested in This Trial?
Interventions
- Educational intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor